A tumor-associated autoantibody panel for the detection of non-small cell lung cancer

Lung cancer is the second most frequent malignancy and the leading cause of cancer-associated death worldwide. Compared with patients diagnosed at advanced disease stages, early detection of lung cancer significantly improved the 5-year survival rate from 3.3% to 48.8%, which highlights the importan...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Ruijun, Zhao, Feng, Zhou, Haiying, Wang, Zengsong, Lin, Dang, Huang, Lu, Xie, Wenling, Chen, Jiawen, Zhou, Lamei, Zhang, Ni, Huang, Chaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757608/
https://www.ncbi.nlm.nih.gov/pubmed/36531074
http://dx.doi.org/10.3389/fonc.2022.1056572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9757608/
https://www.ncbi.nlm.nih.gov/pubmed/36531074
http://dx.doi.org/10.3389/fonc.2022.1056572

Ejemplares similares